GRDN vs INCY · rev $1.45B vs P/E 14, rev $5.14B
Guardian Pharmacy Services, Inc. (GRDN) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Guardian Pharmacy Services, Inc. (GRDN) is a medical care facilities company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported GRDN revenue for 2025-12-31 was $1.45B. Net income was $49.2M. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. GRDN currently screens at market cap $1.25B.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
GRDN currently screens at market cap $1.25B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the GRDN and INCY stock pages for the full models.
Not investment advice.